Attached files
| file | filename |
|---|---|
| EX-10.7 - OFFER LETTER AGREEMENT - Audentes Therapeutics, Inc. | d307713dex107.htm |
| EX-10.6 - OFFER LETTER AGREEMENT - Audentes Therapeutics, Inc. | d307713dex106.htm |
| S-1 - S-1 - Audentes Therapeutics, Inc. | d307713ds1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Audentes Therapeutics, Inc.:
We consent to the use of our report included incorporated by reference herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Francisco, California
April 6, 2017